Literature DB >> 20392262

Functions of nuclear factor kappaB in bone.

Brendan F Boyce1, Zhenqiang Yao, Lianping Xing.   

Abstract

Nuclear factor kappaB (NF-kappaB) is a set of multifunctional transcription factors that regulate expression of genes involved in numerous normal cellular activities. They also are activated in many inflammatory and neoplastic conditions in which their expression may be stimulated by proinflammatory cytokines. NF-kappaB, in turn, regulates the expression of cytokines and so can mediate autocrine self-amplifying cycles of cytokine release and NF-kappaB activation, leading to maintenance of inflammatory reactions beyond the initial stimulus, as seen in rheumatoid arthritis and asthma. Since discovery of the requirement of NF-kappaB for basal and cytokine-induced osteoclast formation in the mid-1990s, much has been learned about the role of NF-kappaB in bone. NF-kappaB has roles in skeletal development, endochondral ossification, osteoclast and osteoblast functions, and common bone diseases. NF-kappaB inhibitors have been developed, but none have made it to clinical trials for the treatment of common bone diseases. Here we review the roles for NF-kappaB in bone and in common bone diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392262      PMCID: PMC3013362          DOI: 10.1111/j.1749-6632.2009.05315.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  60 in total

1.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

2.  Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.

Authors:  P Dobrzanski; R P Ryseck; R Bravo
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

3.  The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

Authors:  V J Palombella; O J Rando; A L Goldberg; T Maniatis
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

4.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

5.  TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Authors:  Kiyoshi Kanazawa; Akira Kudo
Journal:  J Bone Miner Res       Date:  2004-12-20       Impact factor: 6.741

6.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.

Authors:  Michelle L Chaisson; Daniel G Branstetter; Jonathan M Derry; Allison P Armstrong; Mark E Tometsko; Kiyoshi Takeda; Shizuo Akira; William C Dougall
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

8.  TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways.

Authors:  Cheryle A Séguin; Suzanne M Bernier
Journal:  J Cell Physiol       Date:  2003-12       Impact factor: 6.384

9.  Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

Authors:  Eijiro Jimi; Kazuhiro Aoki; Hiroaki Saito; Fulvio D'Acquisto; Michael J May; Ichiro Nakamura; Testuo Sudo; Takefumi Kojima; Fujio Okamoto; Hidefumi Fukushima; Koji Okabe; Keiichi Ohya; Sankar Ghosh
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

10.  The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.

Authors:  H C Liou; G P Nolan; S Ghosh; T Fujita; D Baltimore
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  64 in total

Review 1.  Pathways analysis of molecular markers in chronic sinusitis with polyps.

Authors:  Michael P Platt; Zachary Soler; Ralph Metson; Konstantina M Stankovic
Journal:  Otolaryngol Head Neck Surg       Date:  2011-05       Impact factor: 3.497

2.  NF-κB Has a Direct Role in Inhibiting Bmp- and Wnt-Induced Matrix Protein Expression.

Authors:  Rohinton S Tarapore; Jason Lim; Chen Tian; Sandra Pacios; Wenmei Xiao; Daniel Reid; Hancheng Guan; Marcelo Mattos; Bo Yu; Cun-Yu Wang; Dana T Graves
Journal:  J Bone Miner Res       Date:  2015-08-06       Impact factor: 6.741

3.  Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Authors:  Masayoshi Yamaguchi; M Neale Weitzmann
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

4.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

5.  Constitutive Activation of NIK Impairs the Self-Renewal of Hematopoietic Stem/Progenitor Cells and Induces Bone Marrow Failure.

Authors:  Yan Xiu; Wingel Y Xue; Allyn Lambertz; Mariah Leidinger; Katherine Gibson-Corley; Chen Zhao
Journal:  Stem Cells       Date:  2016-11-02       Impact factor: 6.277

Review 6.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

7.  Local administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patient.

Authors:  Duanyang Han; Peixun Zhang; Baoguo Jiang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 8.  NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

Authors:  T-H Lin; J Pajarinen; L Lu; A Nabeshima; L A Cordova; Z Yao; S B Goodman
Journal:  Adv Protein Chem Struct Biol       Date:  2016-12-09       Impact factor: 3.507

9.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

Review 10.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.